Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Baxter price target raised to $98 from $92 at KeyBanc » 06:21
01/04/22
01/04
06:21
01/04/22
06:21
BAX

Baxter

$86.86 /

+1.035 (+1.21%)

, HRC

Hill-Rom

$155.94 /

+ (+0.00%)

KeyBanc analyst Matthew…

KeyBanc analyst Matthew Mishan raised the firm's price target on Baxter (BAX) to $98 from $92 and keeps an Overweight rating on the shares following the earlier than expected Hill-Rom (HRC) deal close. The analyst believes investors could grow more confident in a long-term thesis around consistent mid-single digit growth trends and a long runway for margin/EPS improvement, while at a reasonable valuation.

ShowHide Related Items >><<
HRC Hill-Rom
$155.94 /

+ (+0.00%)

BAX Baxter
$86.86 /

+1.035 (+1.21%)

BAX Baxter
$86.86 /

+1.035 (+1.21%)

12/17/21 JPMorgan
Baxter reinstated with an Overweight at JPMorgan
11/05/21 Stifel
Hill-Rom downgraded to Hold from Buy at Stifel
10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
HRC Hill-Rom
$155.94 /

+ (+0.00%)

09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
HRC Hill-Rom
$155.94 /

+ (+0.00%)

BAX Baxter
$86.86 /

+1.035 (+1.21%)

BAX Baxter
$86.86 /

+1.035 (+1.21%)

HRC Hill-Rom
$155.94 /

+ (+0.00%)

BAX Baxter
$86.86 /

+1.035 (+1.21%)

HRC Hill-Rom
$155.94 /

+ (+0.00%)

BAX Baxter
$86.86 /

+1.035 (+1.21%)

Over a month ago
Options
One new option listing and fourteen option delistings on December 21st » 08:30
12/21/21
12/21
08:30
12/21/21
08:30
IOT

Samsara

$23.88 /

+1.53 (+6.85%)

, FLXN

Flexion

$9.14 /

+ (+0.00%)

, XLRN

Acceleron

$178.79 /

+ (+0.00%)

, CXP

Columbia Property

$19.29 /

+ (+0.00%)

, CVA

Covanta

$20.25 /

+ (+0.00%)

, RAVN

Raven

$58.05 /

+ (+0.00%)

, PPD

PPD

$47.25 /

+ (+0.00%)

, MDP

Meredith

$59.08 /

+ (+0.00%)

, HRC

Hill-Rom

$155.70 /

+ (+0.00%)

, ADMS

Adamas Pharmaceuticals

$8.22 /

+ (+0.00%)

, ECHO

Echo Global

$48.25 /

+ (+0.00%)

, CAI

CAI International

$55.99 /

+ (+0.00%)

, UFS

Domtar

$55.49 /

+ (+0.00%)

, TRIL

Trillium Therapeutics

$18.45 /

+ (+0.00%)

, INOV

Inovalon

$41.04 /

+ (+0.00%)

New option listings for…

New option listings for December 21st include IOT Stock (IOT). Option delistings effective December 21st include Flexion Therapeutics Inc (FLXN), Acceleron Pharma Inc (XLRN), Columbia Property Trust Inc (CXP), Covanta Holding Corporation (CVA), Raven Industries Inc (RAVN), PPD Inc (PPD), Meredith Corp (MDP), Hill Rom Holdings (HRC), Adamas Pharmaceuticals Inc (ADMS), Echo Global (ECHO), CAI International Inc (CAI), Domtar (UFS), Trillium Therapeutics (TRIL), and Inovalon Holdings Inc (Class A Stock) (INOV).

ShowHide Related Items >><<
XLRN Acceleron
$178.79 /

+ (+0.00%)

UFS Domtar
$55.49 /

+ (+0.00%)

TRIL Trillium Therapeutics
$18.45 /

+ (+0.00%)

RAVN Raven
$58.05 /

+ (+0.00%)

PPD PPD
$47.25 /

+ (+0.00%)

MDP Meredith
$59.08 /

+ (+0.00%)

IOT Samsara
$23.88 /

+1.53 (+6.85%)

INOV Inovalon
$41.04 /

+ (+0.00%)

HRC Hill-Rom
$155.70 /

+ (+0.00%)

FLXN Flexion
$9.14 /

+ (+0.00%)

ECHO Echo Global
$48.25 /

+ (+0.00%)

CXP Columbia Property
$19.29 /

+ (+0.00%)

CVA Covanta
$20.25 /

+ (+0.00%)

CAI CAI International
$55.99 /

+ (+0.00%)

ADMS Adamas Pharmaceuticals
$8.22 /

+ (+0.00%)

IOT Samsara
$23.88 /

+1.53 (+6.85%)

FLXN Flexion
$9.14 /

+ (+0.00%)

11/19/21 Northland
Flexion downgraded to Market Perform from Outperform at Northland
10/19/21 H.C. Wainwright
Flexion downgraded to Neutral from Buy at H.C. Wainwright
10/18/21 Needham
Pacira price target raised to $84 from $80 at Needham
10/12/21 Needham
Flexion downgraded to Hold from Buy at Needham
XLRN Acceleron
$178.79 /

+ (+0.00%)

11/18/21 Stifel
Insmed fits similar 'profile' to Dicerna in terms of value, says Stifel
10/06/21 Jefferies
Acceleron initiated with a Hold at Jefferies
10/04/21 Raymond James
Acceleron downgraded to Market Perform from Strong Buy at Raymond James
10/01/21 Barclays
Acceleron downgraded to Equal Weight from Overweight at Barclays
CXP Columbia Property
$19.29 /

+ (+0.00%)

09/07/21 BMO Capital
Columbia Property downgraded to Market Perform from Outperform at BMO Capital
06/15/21 Truist
Columbia Property price target raised to $19 from $16 at Truist
06/14/21 Wolfe Research
Columbia Property initiated with a Peer Perform at Wolfe Research
04/29/21
Columbia Property sees FY21 normalized FFO $1.23-$1.30, consensus $1.32
CVA Covanta
$20.25 /

+ (+0.00%)

07/15/21
Fly Intel: Top five analyst downgrades
07/15/21 UBS
Covanta downgraded to Neutral from Buy at UBS
07/15/21 Stifel
Covanta downgraded to Hold from Buy at Stifel
06/10/21 Stifel
Covanta could be valued at $17 to 'about $24' in theoretical sale, says Stifel
RAVN Raven
$58.05 /

+ (+0.00%)

06/24/21 CJS Securities
Raven downgraded to Market Perform from Outperform at CJS Securities
06/22/21
Fly Intel: Top five analyst downgrades
06/22/21 Lake Street
Raven downgraded to Hold from Buy at Lake Street
06/21/21 Baird
CNH deal for Raven a long-term positive for dealer Titan, says Baird
PPD PPD
$47.25 /

+ (+0.00%)

08/04/21 Credit Suisse
PPD assumed with a Neutral at Credit Suisse
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
04/28/21 JPMorgan
PPD downgraded to Neutral from Overweight at JPMorgan
04/20/21 Jefferies
PPD downgraded to Hold from Buy at Jefferies
MDP Meredith
$59.08 /

+ (+0.00%)

11/08/21 Piper Sandler
IAC price target raised to $168 from $158 at Piper Sandler
11/04/21 Barclays
IAC price target raised to $190 from $150 at Barclays
10/08/21 Citi
Meredith downgraded to Neutral from Buy at Citi
10/07/21 Benchmark
IAC price target raised to $218 from $200 at Benchmark
HRC Hill-Rom
$155.70 /

+ (+0.00%)

11/05/21 Stifel
Hill-Rom downgraded to Hold from Buy at Stifel
10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
ADMS Adamas Pharmaceuticals
$8.22 /

+ (+0.00%)

12/01/21 Jefferies
Supernus resumed with a Buy at Jefferies
11/17/21 Northland
Adamas Pharmaceuticals downgraded to Market Perform from Outperform at Northland
10/12/21 JMP Securities
Adamas Pharmaceuticals cut to Market Perform from Outperform at JMP Securities
10/12/21 H.C. Wainwright
Adamas Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
ECHO Echo Global
$48.25 /

+ (+0.00%)

09/21/21 Barrington
Echo Global downgraded to Market Perform from Outperform at Barrington
09/13/21 Stifel
Echo Global downgraded to Hold from Buy at Stifel
09/13/21 Truist
Echo Global downgraded to Hold from Buy at Truist
06/29/21 Truist
Echo Global price target lowered to $36 from $37 at Truist
CAI CAI International
$55.99 /

+ (+0.00%)

06/29/21 Keefe Bruyette
CAI downgraded to Market Perform from Outperform at Keefe Bruyette
06/21/21
Fly Intel: Top five analyst downgrades
06/21/21 William Blair
CAI International downgraded to Market Perform from Outperform at William Blair
06/18/21 B. Riley
CAI International downgraded to Neutral from Buy at B. Riley
UFS Domtar
$55.49 /

+ (+0.00%)

07/16/21 BMO Capital
Domtar downgraded to Market Perform from Outperform at BMO Capital
07/06/21 TD Securities
Domtar downgraded to Tender from Hold at TD Securities
05/07/21 RBC Capital
Domtar price target raised to $43 from $40 at RBC Capital
05/07/21 BMO Capital
Domtar price target raised to $53 from $40 at BMO Capital
TRIL Trillium Therapeutics
$18.45 /

+ (+0.00%)

11/17/21 Benchmark
Trillium Therapeutics downgraded to Hold from Buy at Benchmark
08/24/21 Craig-Hallum
Trillium Therapeutics downgraded to Hold at Craig-Hallum
08/24/21 Craig-Hallum
Trillium Therapeutics downgraded to Hold from Buy at Craig-Hallum
08/24/21 JMP Securities
Trillium downgraded to Market Perform from Outperform at JMP Securities
INOV Inovalon
$41.04 /

+ (+0.00%)

08/26/21 Piper Sandler
Inovalon upgraded to Neutral from Underweight at Piper Sandler
08/24/21 KeyBanc
Inovalon downgraded to Sector Weight from Overweight at KeyBanc
08/19/21 BTIG
Inovalon downgraded to Neutral from Buy at BTIG
08/19/21 SVB Leerink
Inovalon downgraded to Market Perform from Outperform at SVB Leerink
XLRN Acceleron
$178.79 /

+ (+0.00%)

TRIL Trillium Therapeutics
$18.45 /

+ (+0.00%)

RAVN Raven
$58.05 /

+ (+0.00%)

PPD PPD
$47.25 /

+ (+0.00%)

MDP Meredith
$59.08 /

+ (+0.00%)

INOV Inovalon
$41.04 /

+ (+0.00%)

HRC Hill-Rom
$155.70 /

+ (+0.00%)

FLXN Flexion
$9.14 /

+ (+0.00%)

ECHO Echo Global
$48.25 /

+ (+0.00%)

CVA Covanta
$20.25 /

+ (+0.00%)

ADMS Adamas Pharmaceuticals
$8.22 /

+ (+0.00%)

  • 15
    Dec
  • 25
    Feb
XLRN Acceleron
$178.79 /

+ (+0.00%)

MDP Meredith
$59.08 /

+ (+0.00%)

INOV Inovalon
$41.04 /

+ (+0.00%)

HRC Hill-Rom
$155.70 /

+ (+0.00%)

XLRN Acceleron
$178.79 /

+ (+0.00%)

TRIL Trillium Therapeutics
$18.45 /

+ (+0.00%)

RAVN Raven
$58.05 /

+ (+0.00%)

MDP Meredith
$59.08 /

+ (+0.00%)

IOT Samsara
$23.88 /

+1.53 (+6.85%)

INOV Inovalon
$41.04 /

+ (+0.00%)

HRC Hill-Rom
$155.70 /

+ (+0.00%)

FLXN Flexion
$9.14 /

+ (+0.00%)

ECHO Echo Global
$48.25 /

+ (+0.00%)

CVA Covanta
$20.25 /

+ (+0.00%)

TRIL Trillium Therapeutics
$18.45 /

+ (+0.00%)

RAVN Raven
$58.05 /

+ (+0.00%)

Hot Stocks
Alcoa to replace Hill-Rom in S&P 400 at open on 12/20 » 04:55
12/20/21
12/20
04:55
12/20/21
04:55
AA

Alcoa

$53.68 /

+1.065 (+2.02%)

, HRC

Hill-Rom

$155.70 /

+ (+0.00%)

, BAX

Baxter

$83.67 /

-0.28 (-0.33%)

Baxter (BAX) is acquiring…

Baxter (BAX) is acquiring Hill-Rom (HRC) in a deal that was completed on December 13.

ShowHide Related Items >><<
HRC Hill-Rom
$155.70 /

+ (+0.00%)

BAX Baxter
$83.67 /

-0.28 (-0.33%)

AA Alcoa
$53.68 /

+1.065 (+2.02%)

AA Alcoa
$53.68 /

+1.065 (+2.02%)

11/16/21 Wolfe Research
Alcoa initiated with an Outperform at Wolfe Research
11/02/21
Fly Intel: Top five analyst upgrades
11/02/21 Jefferies
Alcoa upgraded to Buy from Hold at Jefferies
11/02/21 Jefferies
Alcoa upgraded to Buy from Hold at Jefferies
HRC Hill-Rom
$155.70 /

+ (+0.00%)

11/05/21 Stifel
Hill-Rom downgraded to Hold from Buy at Stifel
10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
BAX Baxter
$83.67 /

-0.28 (-0.33%)

12/17/21 JPMorgan
Baxter reinstated with an Overweight at JPMorgan
HRC Hill-Rom
$155.70 /

+ (+0.00%)

BAX Baxter
$83.67 /

-0.28 (-0.33%)

AA Alcoa
$53.68 /

+1.065 (+2.02%)

HRC Hill-Rom
$155.70 /

+ (+0.00%)

AA Alcoa
$53.68 /

+1.065 (+2.02%)

HRC Hill-Rom
$155.70 /

+ (+0.00%)

BAX Baxter
$83.67 /

-0.28 (-0.33%)

AA Alcoa
$53.68 /

+1.065 (+2.02%)

BAX Baxter
$83.67 /

-0.28 (-0.33%)

AA Alcoa
$53.68 /

+1.065 (+2.02%)

Hot Stocks
Alcoa to replace Hill-Rom in S&P 400 at open on 12/20 » 17:19
12/13/21
12/13
17:19
12/13/21
17:19
AA

Alcoa

$47.78 /

-1.04 (-2.13%)

, HRC

Hill-Rom

$155.94 /

+ (+0.00%)

, BAX

Baxter

$83.23 /

+2.335 (+2.89%)

Baxter (BAX) is acquiring…

Baxter (BAX) is acquiring Hill-Rom (HRC) in a deal that was completed on December 13.

ShowHide Related Items >><<
HRC Hill-Rom
$155.94 /

+ (+0.00%)

BAX Baxter
$83.23 /

+2.335 (+2.89%)

AA Alcoa
$47.78 /

-1.04 (-2.13%)

AA Alcoa
$47.78 /

-1.04 (-2.13%)

11/16/21 Wolfe Research
Alcoa initiated with an Outperform at Wolfe Research
11/02/21
Fly Intel: Top five analyst upgrades
11/02/21 Jefferies
Alcoa upgraded to Buy from Hold at Jefferies
11/02/21 Jefferies
Alcoa upgraded to Buy from Hold at Jefferies
HRC Hill-Rom
$155.94 /

+ (+0.00%)

11/05/21 Stifel
Hill-Rom downgraded to Hold from Buy at Stifel
10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
BAX Baxter
$83.23 /

+2.335 (+2.89%)

HRC Hill-Rom
$155.94 /

+ (+0.00%)

BAX Baxter
$83.23 /

+2.335 (+2.89%)

AA Alcoa
$47.78 /

-1.04 (-2.13%)

HRC Hill-Rom
$155.94 /

+ (+0.00%)

AA Alcoa
$47.78 /

-1.04 (-2.13%)

HRC Hill-Rom
$155.94 /

+ (+0.00%)

BAX Baxter
$83.23 /

+2.335 (+2.89%)

AA Alcoa
$47.78 /

-1.04 (-2.13%)

BAX Baxter
$83.23 /

+2.335 (+2.89%)

AA Alcoa
$47.78 /

-1.04 (-2.13%)

Hot Stocks
Hillrom shareholders approve acquisition by Baxter » 17:49
12/02/21
12/02
17:49
12/02/21
17:49
HRC

Hill-Rom

$155.74 /

+0.07 (+0.04%)

, BAX

Baxter

$76.26 /

+1.46 (+1.95%)

Hillrom (HRC) announced…

Hillrom (HRC) announced that its shareholders have voted to approve the previously announced pending acquisition by Baxter International Inc. (BAX) at a special meeting. Hillrom shareholders voted overwhelmingly in favor of the transaction. Under the terms of the merger agreement, Hillrom shareholders will receive $156.00 per share in cash for every share of Hillrom stock they own immediately prior to the effective time of the merger. Based on a preliminary tabulation of the shareholder vote, approximately 99% of all votes cast, which represents approximately 70% of all outstanding shares on October 18, 2021, the record date for the special meeting, were voted in favor of the merger. The transaction is subject to customary closing conditions, including the receipt of required regulatory approvals. The transaction is expected to close in 2021 or early 2022.

ShowHide Related Items >><<
HRC Hill-Rom
$155.74 /

+0.07 (+0.04%)

BAX Baxter
$76.26 /

+1.46 (+1.95%)

HRC Hill-Rom
$155.74 /

+0.07 (+0.04%)

11/05/21 Stifel
Hill-Rom downgraded to Hold from Buy at Stifel
10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
BAX Baxter
$76.26 /

+1.46 (+1.95%)

HRC Hill-Rom
$155.74 /

+0.07 (+0.04%)

BAX Baxter
$76.26 /

+1.46 (+1.95%)

HRC Hill-Rom
$155.74 /

+0.07 (+0.04%)

HRC Hill-Rom
$155.74 /

+0.07 (+0.04%)

BAX Baxter
$76.26 /

+1.46 (+1.95%)

BAX Baxter
$76.26 /

+1.46 (+1.95%)

Hot Stocks
Soros Fund buys Hill-Rom, exits Wayfair in Q3 » 17:10
11/12/21
11/12
17:10
11/12/21
17:10
HRC

Hill-Rom

$155.06 /

-0.06 (-0.04%)

, JPM

JPMorgan

$166.86 /

-0.745 (-0.44%)

, UNH

UnitedHealth

$458.98 /

+1.765 (+0.39%)

, CPNG

Coupang

$26.58 /

-2.59 (-8.88%)

, EQT

EQT Corporation

$21.35 /

+0.16 (+0.76%)

, OTIS

Otis Worldwide

$85.54 /

+2.13 (+2.55%)

, QS

QuantumScape

$38.87 /

-0.835 (-2.10%)

, CLVT

Clarivate

$23.21 /

+0.53 (+2.34%)

, IFF

IFF

$152.59 /

+2.3 (+1.53%)

, W

Wayfair

$257.82 /

+13.575 (+5.56%)

, INFO

IHS Markit

$125.90 /

+2.38 (+1.93%)

, NUAN

Nuance

$54.87 /

-0.095 (-0.17%)

, PPD

PPD

$47.27 /

+0.065 (+0.14%)

, ARMK

Aramark

$37.95 /

-0.295 (-0.77%)

, CRM

Salesforce

$306.64 /

+3.635 (+1.20%)

, FIGS

Figs

$35.04 /

+0.94 (+2.76%)

, QQQ

Invesco QQQ Trust

$394.73 /

+4.09 (+1.05%)

, ATVI

Activision Blizzard

$69.74 /

+2.26 (+3.35%)

, MGLN

Magellan Health

$94.74 /

-0.11 (-0.12%)

, ELAN

Elanco

$33.03 /

+0.29 (+0.89%)

, LBRDK

Liberty Broadband

$167.22 /

-0.34 (-0.20%)

, DHI

D.R. Horton

$97.83 /

+1.46 (+1.51%)

, AMZN

Amazon.com

$3,526.52 /

+54.655 (+1.57%)

George Soros' Soros…

George Soros' Soros Fund Management dislcosed in an SEC filing its holdings as of September 30, 2021. The fund's 65 new buys during the third quarter included, by size of position, Hill-Rom (HRC), JPMorgan (JPM), UnitedHealth (UNH), Coupang (CPNG), and EQT Corp. (EQT). Soros Fund exited 57 positions during the quarter, including by size of previous position Otis Worldwide (OTIS), QuantumScape (QS), Clarivate (CLVT), IFF (IFF), and Wayfair (W). The fund increased its stake in 30 holdings, including by size of previous position IHS Markit (INFO), Nuance Communications (NUAN), PPD Inc. (PPD), Aramark (ARMK), and Salesforce.com (CRM). Soros reduced its stake in 19 holdings, including by size of previous position Figs Class A (FIGS), Invesco QQQ Trust Series 1 (QQQ), Activision Blizzard (ATVI), Magellan Health (MGLN), and Elanco Animal Health (ELAN). The fund's top holdings as of September 30, in order of size, were Liberty Broadband Class C (LBRDK), DR Horton (DHI), Invesco QQQ Trust Series 1, Amazon (AMZN), and IHS Markit.

ShowHide Related Items >><<
W Wayfair
$257.82 /

+13.575 (+5.56%)

UNH UnitedHealth
$458.98 /

+1.765 (+0.39%)

QS QuantumScape
$38.87 /

-0.835 (-2.10%)

QQQ Invesco QQQ Trust
$394.73 /

+4.09 (+1.05%)

PPD PPD
$47.27 /

+0.065 (+0.14%)

OTIS Otis Worldwide
$85.54 /

+2.13 (+2.55%)

NUAN Nuance
$54.87 /

-0.095 (-0.17%)

MGLN Magellan Health
$94.74 /

-0.11 (-0.12%)

LBRDK Liberty Broadband
$167.22 /

-0.34 (-0.20%)

JPM JPMorgan
$166.86 /

-0.745 (-0.44%)

INFO IHS Markit
$125.90 /

+2.38 (+1.93%)

IFF IFF
$152.59 /

+2.3 (+1.53%)

HRC Hill-Rom
$155.06 /

-0.06 (-0.04%)

FIGS Figs
$35.04 /

+0.94 (+2.76%)

EQT EQT Corporation
$21.35 /

+0.16 (+0.76%)

ELAN Elanco
$33.03 /

+0.29 (+0.89%)

DHI D.R. Horton
$97.83 /

+1.46 (+1.51%)

CRM Salesforce
$306.64 /

+3.635 (+1.20%)

CPNG Coupang
$26.58 /

-2.59 (-8.88%)

CLVT Clarivate
$23.21 /

+0.53 (+2.34%)

ATVI Activision Blizzard
$69.74 /

+2.26 (+3.35%)

ARMK Aramark
$37.95 /

-0.295 (-0.77%)

AMZN Amazon.com
$3,526.52 /

+54.655 (+1.57%)

HRC Hill-Rom
$155.06 /

-0.06 (-0.04%)

11/05/21 Stifel
Hill-Rom downgraded to Hold from Buy at Stifel
10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
JPM JPMorgan
$166.86 /

-0.745 (-0.44%)

10/25/21 Wells Fargo
JPMorgan price target raised to $210 from $200 at Wells Fargo
10/15/21 Barclays
JPMorgan price target raised to $193 from $187 at Barclays
10/14/21 BMO Capital
JPMorgan price target raised to $140 from $139 at BMO Capital
10/11/21 Jefferies
JPMorgan price target raised to $198 from $177 at Jefferies
UNH UnitedHealth
$458.98 /

+1.765 (+0.39%)

11/11/21 Barclays
MultiPlan price target lowered to $6 from $7 at Barclays
11/10/21 Mizuho
UnitedHealth price target raised to $500 from $455 at Mizuho
11/03/21 Piper Sandler
Piper ups Tivity Health target to $27 after results, ahead of contract renewal
10/25/21 Wells Fargo
UnitedHealth price target raised to $520 from $478 at Wells Fargo
CPNG Coupang
$26.58 /

-2.59 (-8.88%)

10/12/21 Citi
Coupang price target lowered to $32 from $39 at Citi
08/26/21 Daiwa
Coupang upgraded to Buy on improving fundamentals at Daiwa
08/26/21 Daiwa
Coupang upgraded to Buy from Outperform at Daiwa
08/12/21 Deutsche Bank
Coupang upgraded to Buy after earnings at Deutsche Bank
EQT EQT Corporation
$21.35 /

+0.16 (+0.76%)

10/29/21 JPMorgan
JPMorgan upgrades EQT Corporation with 'bear narrative' played out
10/29/21 JPMorgan
EQT Corporation upgraded to Overweight from Neutral at JPMorgan
10/18/21 Mizuho
EQT Corporation price target raised to $35 from $29 at Mizuho
10/07/21 Truist
EQT Corporation price target raised to $34 from $29 at Truist
OTIS Otis Worldwide
$85.54 /

+2.13 (+2.55%)

10/07/21 Wells Fargo
Wells Fargo starts Otis Worldwide at Underweight, sees better value elsewhere
10/07/21 Wells Fargo
Otis Worldwide initiated with an Underweight at Wells Fargo
10/04/21 Barclays
Otis Worldwide price target raised to $89 from $86 at Barclays
09/20/21 JPMorgan
Otis Worldwide recent share pullback overdone, says JPMorgan
QS QuantumScape
$38.87 /

-0.835 (-2.10%)

07/21/21
Fly Intel: Top five analyst initiations
07/21/21 JPMorgan
QuantumScape initiated with Neutral, $35 target at JPMorgan
07/20/21 JPMorgan
QuantumScape initiated with a Neutral at JPMorgan
06/17/21 Wolfe Research
QuantumScape initiated with a Peer Perform at Wolfe Research
CLVT Clarivate
$23.21 /

+0.53 (+2.34%)

08/16/21 BofA
BofA starts Clarivate at Buy on attractive valuation, predictable model
08/16/21 BofA
Clarivate initiated with a Buy at BofA
08/04/21 RBC Capital
Clarivate assumed with an Outperform at RBC Capital
06/25/21 Morgan Stanley
Clarivate 'the best short-term trade' in business services, says Morgan Stanley
IFF IFF
$152.59 /

+2.3 (+1.53%)

11/12/21 Deutsche Bank
IFF price target raised to $170 from $162 at Deutsche Bank
11/10/21 Wells Fargo
IFF price target raised to $170 from $160 at Wells Fargo
11/10/21 JPMorgan
IFF price target raised to $165 from $163 at JPMorgan
10/12/21 Mizuho
IFF initiated with a Neutral at Mizuho
W Wayfair
$257.82 /

+13.575 (+5.56%)

11/08/21 Citi
Wayfair price target lowered to $200 from $225 at Citi
11/05/21 DA Davidson
Wayfair price target lowered to $360 from $415 at DA Davidson
11/05/21 Wedbush
Wayfair price target lowered to $290 from $300 at Wedbush
11/04/21 Wells Fargo
Wayfair price target lowered to $250 from $285 at Wells Fargo
INFO IHS Markit
$125.90 /

+2.38 (+1.93%)

09/16/21 Oppenheimer
S&P Global price target raised to $550 from $476 at Oppenheimer
07/15/21 Deutsche Bank
IHS Markit price target raised to $127 from $123 at Deutsche Bank
07/15/21 Deutsche Bank
S&P Global price target raised to $450 from $435 at Deutsche Bank
07/07/21 RBC Capital
S&P Global initiated with an Outperform at RBC Capital
NUAN Nuance
$54.87 /

-0.095 (-0.17%)

05/11/21 Morgan Stanley
Morgan Stanley downgrades Nuance, doesn't see Microsoft deal being beat
05/11/21 Morgan Stanley
Nuance downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/21 Morgan Stanley
Morgan Stanley says Microsoft 'uniquely positioned' for synergies with Nuance
04/13/21 Craig-Hallum
Nuance downgraded to Hold from Buy at Craig-Hallum
PPD PPD
$47.27 /

+0.065 (+0.14%)

08/04/21 Credit Suisse
PPD assumed with a Neutral at Credit Suisse
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
04/28/21 JPMorgan
PPD downgraded to Neutral from Overweight at JPMorgan
04/20/21 Jefferies
PPD downgraded to Hold from Buy at Jefferies
ARMK Aramark
$37.95 /

-0.295 (-0.77%)

10/21/21
Fly Intel: Top five analyst upgrades
10/21/21 Berenberg
Aramark upgraded to Buy after share underperformance at Berenberg
10/21/21 Berenberg
Aramark upgraded to Buy from Hold at Berenberg
09/17/21 Barclays
Aramark downgraded to Underweight from Equal Weight at Barclays
CRM Salesforce
$306.64 /

+3.635 (+1.20%)

11/01/21 Deutsche Bank
Salesforce initiated with a Buy at Deutsche Bank
11/01/21 Morgan Stanley
Salesforce price target raised to $360 from $345 at Morgan Stanley
09/24/21
Fly Intel: Top five analyst upgrades
09/24/21 RBC Capital
Salesforce price target raised to $325 from $310 at RBC Capital
FIGS Figs
$35.04 /

+0.94 (+2.76%)

11/02/21 Piper Sandler
Figs risk/reward favorable into Q3 results, says Piper Sandler
06/21/21 Guggenheim
Figs initiated with a Buy at Guggenheim
06/21/21 Cowen
Cowen starts Figs at Outperform, sees path to market cap over $8B
06/21/21
Fly Intel: Top five analyst initiations
QQQ Invesco QQQ Trust
$394.73 /

+4.09 (+1.05%)

ATVI Activision Blizzard
$69.74 /

+2.26 (+3.35%)

11/03/21
Fly Intel: Top five analyst downgrades
11/03/21 MKM Partners
Activision Blizzard downgraded to Neutral from Buy at MKM Partners
11/03/21 MKM Partners
Activision Blizzard downgraded to Neutral from Buy at MKM Partners
11/03/21 Oppenheimer
Activision Blizzard price target lowered to $85 from $100 at Oppenheimer
MGLN Magellan Health
$94.74 /

-0.11 (-0.12%)

01/15/21 Jefferies
Magellan Health downgraded to Hold after takeover agreement at Jefferies
01/15/21 Jefferies
Jefferies downgrades Centene to Hold, sees Dem win benefits pulled forward
01/15/21 Jefferies
Magellan Health downgraded to Hold from Buy at Jefferies
01/06/21 Stephens
Magellan Health downgraded to Equal Weight from Overweight at Stephens
ELAN Elanco
$33.03 /

+0.29 (+0.89%)

10/28/21
Fly Intel: Top five analyst downgrades
10/28/21 Stifel
Elanco downgraded to Hold from Buy at Stifel
08/24/21 JPMorgan
Elanco 10% pullback brings buying opportunity, says JPMorgan
08/23/21 Alliance Global Partners
Kindred downgraded to Neutral from Buy at Alliance Global Partners
LBRDK Liberty Broadband
$167.22 /

-0.34 (-0.20%)

08/24/21 Pivotal Research
Liberty Broadband price target raised to $267 from $226 at Pivotal Research
06/18/21 TD Securities
Liberty Broadband price target raised to $215 from $210 at TD Securities
06/02/21 Citi
Liberty Broadband price target raised to $198 from $193 at Citi
05/24/21 Benchmark
Benchmark does not 'attach any credence' to idea AT&T could buy Charter
DHI D.R. Horton
$97.83 /

+1.46 (+1.51%)

11/11/21 Citi
D.R. Horton price target raised to $116 from $104 at Citi
11/10/21 Barclays
D.R. Horton price target raised to $122 from $109 at Barclays
11/08/21 BofA
D.R. Horton reinstated with a Buy at BofA
10/14/21 JPMorgan
D.R. Horton price target lowered to $115 from $129 at JPMorgan
AMZN Amazon.com
$3,526.52 /

+54.655 (+1.57%)

11/11/21 RBC Capital
Affirm price target raised to $175 from $130 at RBC Capital
11/11/21 Credit Suisse
Affirm price target raised to $150 from $105 at Credit Suisse
11/11/21 Barclays
Affirm's expanded Amazon deal not reflected in outlook, says Barclays
11/10/21 Tigress Financial
Amazon.com price target raised to $4,460 from $4,370 at Tigress Financial
W Wayfair
$257.82 /

+13.575 (+5.56%)

UNH UnitedHealth
$458.98 /

+1.765 (+0.39%)

QS QuantumScape
$38.87 /

-0.835 (-2.10%)

PPD PPD
$47.27 /

+0.065 (+0.14%)

OTIS Otis Worldwide
$85.54 /

+2.13 (+2.55%)

NUAN Nuance
$54.87 /

-0.095 (-0.17%)

MGLN Magellan Health
$94.74 /

-0.11 (-0.12%)

JPM JPMorgan
$166.86 /

-0.745 (-0.44%)

INFO IHS Markit
$125.90 /

+2.38 (+1.93%)

IFF IFF
$152.59 /

+2.3 (+1.53%)

HRC Hill-Rom
$155.06 /

-0.06 (-0.04%)

FIGS Figs
$35.04 /

+0.94 (+2.76%)

EQT EQT Corporation
$21.35 /

+0.16 (+0.76%)

ELAN Elanco
$33.03 /

+0.29 (+0.89%)

DHI D.R. Horton
$97.83 /

+1.46 (+1.51%)

CRM Salesforce
$306.64 /

+3.635 (+1.20%)

CPNG Coupang
$26.58 /

-2.59 (-8.88%)

CLVT Clarivate
$23.21 /

+0.53 (+2.34%)

ATVI Activision Blizzard
$69.74 /

+2.26 (+3.35%)

ARMK Aramark
$37.95 /

-0.295 (-0.77%)

AMZN Amazon.com
$3,526.52 /

+54.655 (+1.57%)

  • 29
    Sep
  • 16
    Sep
  • 14
    Sep
  • 10
    Sep
  • 29
    Jun
  • 10
    Jun
  • 27
    May
  • 11
    May
  • 25
    Mar
  • 11
    Mar
  • 01
    Dec
W Wayfair
$257.82 /

+13.575 (+5.56%)

UNH UnitedHealth
$458.98 /

+1.765 (+0.39%)

QS QuantumScape
$38.87 /

-0.835 (-2.10%)

LBRDK Liberty Broadband
$167.22 /

-0.34 (-0.20%)

JPM JPMorgan
$166.86 /

-0.745 (-0.44%)

INFO IHS Markit
$125.90 /

+2.38 (+1.93%)

HRC Hill-Rom
$155.06 /

-0.06 (-0.04%)

DHI D.R. Horton
$97.83 /

+1.46 (+1.51%)

CRM Salesforce
$306.64 /

+3.635 (+1.20%)

CPNG Coupang
$26.58 /

-2.59 (-8.88%)

ATVI Activision Blizzard
$69.74 /

+2.26 (+3.35%)

AMZN Amazon.com
$3,526.52 /

+54.655 (+1.57%)

W Wayfair
$257.82 /

+13.575 (+5.56%)

UNH UnitedHealth
$458.98 /

+1.765 (+0.39%)

QS QuantumScape
$38.87 /

-0.835 (-2.10%)

OTIS Otis Worldwide
$85.54 /

+2.13 (+2.55%)

JPM JPMorgan
$166.86 /

-0.745 (-0.44%)

INFO IHS Markit
$125.90 /

+2.38 (+1.93%)

IFF IFF
$152.59 /

+2.3 (+1.53%)

HRC Hill-Rom
$155.06 /

-0.06 (-0.04%)

FIGS Figs
$35.04 /

+0.94 (+2.76%)

EQT EQT Corporation
$21.35 /

+0.16 (+0.76%)

ELAN Elanco
$33.03 /

+0.29 (+0.89%)

DHI D.R. Horton
$97.83 /

+1.46 (+1.51%)

CRM Salesforce
$306.64 /

+3.635 (+1.20%)

CPNG Coupang
$26.58 /

-2.59 (-8.88%)

CLVT Clarivate
$23.21 /

+0.53 (+2.34%)

ATVI Activision Blizzard
$69.74 /

+2.26 (+3.35%)

ARMK Aramark
$37.95 /

-0.295 (-0.77%)

AMZN Amazon.com
$3,526.52 /

+54.655 (+1.57%)

W Wayfair
$257.82 /

+13.575 (+5.56%)

UNH UnitedHealth
$458.98 /

+1.765 (+0.39%)

QS QuantumScape
$38.87 /

-0.835 (-2.10%)

OTIS Otis Worldwide
$85.54 /

+2.13 (+2.55%)

NUAN Nuance
$54.87 /

-0.095 (-0.17%)

JPM JPMorgan
$166.86 /

-0.745 (-0.44%)

IFF IFF
$152.59 /

+2.3 (+1.53%)

FIGS Figs
$35.04 /

+0.94 (+2.76%)

EQT EQT Corporation
$21.35 /

+0.16 (+0.76%)

DHI D.R. Horton
$97.83 /

+1.46 (+1.51%)

CRM Salesforce
$306.64 /

+3.635 (+1.20%)

CPNG Coupang
$26.58 /

-2.59 (-8.88%)

ATVI Activision Blizzard
$69.74 /

+2.26 (+3.35%)

AMZN Amazon.com
$3,526.52 /

+54.655 (+1.57%)

QQQ Invesco QQQ Trust
$394.73 /

+4.09 (+1.05%)

Downgrade
Hill-Rom downgraded to Hold from Buy at Stifel » 13:09
11/05/21
11/05
13:09
11/05/21
13:09
HRC

Hill-Rom

$155.10 /

-0.01 (-0.01%)

, BAX

Baxter

$78.12 /

-0.2 (-0.26%)

Stifel analyst Rick Wise…

Stifel analyst Rick Wise downgraded Hill-Rom (HRC) to Hold from Buy with a price target of $156, up from $155, after the company's CEO John Groetelaars indicated that the combination with Baxter (BAX) remains on track to close by "early 2022," as expected. In light of that potential transaction close and the stock's recent stock move towards the $156 deal price, he lowered his rating, Wise said.

ShowHide Related Items >><<
HRC Hill-Rom
$155.10 /

-0.01 (-0.01%)

BAX Baxter
$78.12 /

-0.2 (-0.26%)

HRC Hill-Rom
$155.10 /

-0.01 (-0.01%)

10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
09/07/21 KeyBanc
Hill-Rom downgraded to Sector Weight from Overweight at KeyBanc
BAX Baxter
$78.12 /

-0.2 (-0.26%)

09/13/21 Cowen
Baxter upgraded to Outperform from Market Perform at Cowen
HRC Hill-Rom
$155.10 /

-0.01 (-0.01%)

BAX Baxter
$78.12 /

-0.2 (-0.26%)

HRC Hill-Rom
$155.10 /

-0.01 (-0.01%)

HRC Hill-Rom
$155.10 /

-0.01 (-0.01%)

BAX Baxter
$78.12 /

-0.2 (-0.26%)

BAX Baxter
$78.12 /

-0.2 (-0.26%)

Earnings
Hill-Rom reports Q4 adjusted EPS $1.67, consensus $1.47 » 07:09
11/05/21
11/05
07:09
11/05/21
07:09
HRC

Hill-Rom

$155.11 /

+0.02 (+0.01%)

Reports Q4 revenue…

Reports Q4 revenue $797.9M, consensus $752.93M. "We delivered yet another strong quarter to conclude a very successful year for Hillrom, resulting in record financial performance for fiscal 2021," said John Groetelaars, Hillrom president and CEO. "I am very proud of the global Hillrom team for their unwavering commitment and resiliency, and the tremendous value they have created for patients, caregivers, and our shareholders as we continue to advance our vision of connected care."

ShowHide Related Items >><<
HRC Hill-Rom
$155.11 /

+0.02 (+0.01%)

HRC Hill-Rom
$155.11 /

+0.02 (+0.01%)

10/28/21 Piper Sandler
Piper Sandler keeps a Neutral rating on Baxter following quarterly results
09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
09/07/21 KeyBanc
Hill-Rom downgraded to Sector Weight from Overweight at KeyBanc
HRC Hill-Rom
$155.11 /

+0.02 (+0.01%)

HRC Hill-Rom
$155.11 /

+0.02 (+0.01%)

HRC Hill-Rom
$155.11 /

+0.02 (+0.01%)

Recommendations
Piper Sandler keeps a Neutral rating on Baxter following quarterly results » 15:45
10/28/21
10/28
15:45
10/28/21
15:45
BAX

Baxter

$78.53 /

-3.41 (-4.16%)

, HRC

Hill-Rom

$154.88 /

+0.3 (+0.19%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien notes Baxter (BAX) reported Q3 revenues that met expectations on the top-line and beat on the bottom-line. Management reaffirmed its full-year revenue projections but raised adjusted EPS expectations by eight cents, the analyst adds. The Q4 outlook implies sequential improvement to finish the year, yet falls slightly short of his estimates. O'Brien points out that management expects margins to be pressured going into 2022 despite ongoing work with cost containment and efficiency in the supply chain. Lastly, management expressed optimism about the recent Hillrom (HRC) acquisition and upcoming Novum IQ launch, both of which should benefit the top line over the coming years, he adds. While Baxter continues to deliver steady performance and has an "excellent management team at the helm," the lack of near-term catalysts keeps him on the sidelines. The analyst reiterates a Neutral rating and price target of $82 on the shares.

ShowHide Related Items >><<
HRC Hill-Rom
$154.88 /

+0.3 (+0.19%)

BAX Baxter
$78.53 /

-3.41 (-4.16%)

BAX Baxter
$78.53 /

-3.41 (-4.16%)

09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
09/13/21 Cowen
Baxter upgraded to Outperform from Market Perform at Cowen
09/07/21 KeyBanc
Hill-Rom downgraded to Sector Weight from Overweight at KeyBanc
HRC Hill-Rom
$154.88 /

+0.3 (+0.19%)

09/03/21 Barclays
Barclays upgrades Baxter with $100 target after Hill-Rom deal
HRC Hill-Rom
$154.88 /

+0.3 (+0.19%)

BAX Baxter
$78.53 /

-3.41 (-4.16%)

BAX Baxter
$78.53 /

-3.41 (-4.16%)

HRC Hill-Rom
$154.88 /

+0.3 (+0.19%)

BAX Baxter
$78.53 /

-3.41 (-4.16%)

BAX Baxter
$78.53 /

-3.41 (-4.16%)

Over a quarter ago
Conference/Events
Oppenheimer healthcare analysts hold an analyst/industry conference call » 10:25
10/08/21
10/08
10:25
10/08/21
10:25
IRTC

iRhythm

$64.14 /

+0.72 (+1.14%)

, BSX

Boston Scientific

$43.75 /

+0.13 (+0.30%)

, HRC

Hill-Rom

$151.05 /

+0.2 (+0.13%)

, PHG

Philips

$43.34 /

+0.2 (+0.46%)

Healthcare Analysts…

Healthcare Analysts provide an extended ECG monitors update, relevant for IRTC, BSX, HRC and PHG, on an Analyst/Industry conference call to be held on October 8 at 11 am.

ShowHide Related Items >><<
PHG Philips
$43.34 /

+0.2 (+0.46%)

IRTC iRhythm
$64.14 /

+0.72 (+1.14%)

HRC Hill-Rom
$151.05 /

+0.2 (+0.13%)

BSX Boston Scientific
$43.75 /

+0.13 (+0.30%)

IRTC iRhythm
$64.14 /

+0.72 (+1.14%)

10/01/21 Citi
iRhythm price target raised to $60 from $55 at Citi
09/13/21 Baird
iRhythm's new COE has 'quality pedigree,' says Baird
09/13/21 Piper Sandler
DexCom COO departure won't affect momentum, says Piper Sandler
08/26/21 Canaccord
iRhythm price target raised to $236 from $210 at Canaccord
BSX Boston Scientific
$43.75 /

+0.13 (+0.30%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
HRC Hill-Rom
$151.05 /

+0.2 (+0.13%)

09/21/21 Raymond James
Baxter resumed with an Outperform at Raymond James
09/19/21 Morgan Stanley
Hill-Rom downgraded to Equal Weight from Overweight at Morgan Stanley
09/07/21 KeyBanc
Hill-Rom downgraded to Sector Weight from Overweight at KeyBanc
09/03/21 Barclays
Barclays upgrades Baxter with $100 target after Hill-Rom deal
PHG Philips
$43.34 /

+0.2 (+0.46%)

09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
09/08/21
Fly Intel: Top five analyst initiations
09/08/21 Jefferies
Philips initiated with a Buy at Jefferies
08/31/21 ING Bank
Philips upgraded to Buy on recall-related selloff at ING Bank
PHG Philips
$43.34 /

+0.2 (+0.46%)

IRTC iRhythm
$64.14 /

+0.72 (+1.14%)

HRC Hill-Rom
$151.05 /

+0.2 (+0.13%)

BSX Boston Scientific
$43.75 /

+0.13 (+0.30%)

  • 10
    Jun
PHG Philips
$43.34 /

+0.2 (+0.46%)

IRTC iRhythm
$64.14 /

+0.72 (+1.14%)

HRC Hill-Rom
$151.05 /

+0.2 (+0.13%)

BSX Boston Scientific
$43.75 /

+0.13 (+0.30%)

PHG Philips
$43.34 /

+0.2 (+0.46%)

IRTC iRhythm
$64.14 /

+0.72 (+1.14%)

HRC Hill-Rom
$151.05 /

+0.2 (+0.13%)

BSX Boston Scientific
$43.75 /

+0.13 (+0.30%)

BSX Boston Scientific
$43.75 /

+0.13 (+0.30%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.